41
Participants
Start Date
June 21, 2022
Primary Completion Date
January 22, 2024
Study Completion Date
January 22, 2024
Loncastuximab Tesirine
Intravenous (IV) Infusion
Rituximab
Cycle 1 - Intravenous (IV) Infusion. Cycle 2+ - Intravenous (IV) Infusion or Subcutaneous (SC) Administration.
Hospital San Pedro de Alcantara, Cáceres
New York Cancer & Blood Specialists - New Hyde Park, Babylon
New York Cancer & Blood Specialists - Babylon Medical Oncology, Port Jefferson
Ospedaliera Santi Antonio E Biagio E Cesare Arrigo-SC Ematologia, Alessandria
Reading Hospital - Tower Health, Reading
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan
USOR - Virginia Cancer Specialists - Gainesville Office, Gainesville
Virginia Cancer Institute - West End, Richmond
USOR - Virginia Oncology Associates, Virginia Beach
Blue Ridge Cancer Care - Blacksburg, Blacksburg
Azienda Socio Sanitaria Territoriale (ASST) degli Spedali Civili di Brescia, Brescia
Hospital Universitario Ramón y Cajal, Madrid
Hospital Universitario Fundación Jiménez Díaz, Madrid
Novant Health Cancer Specialists - Charlotte, Charlotte
Prisma Health Cancer Institute, Greenville
Clinica Universidad de Navarra - Pamplona, Pamplona
Hospital Universitario Marqués de Valdecilla, Santander
Leonard Lawson Cancer Center, Pikeville
Ohio Health - Research and Innovation Institute, Columbus
University Hospitals Cleveland Medical Center, Cleveland
USOR - Oncology Hematology Care - Kenwood, Cincinnati
Hospital Arnau de Vilanova, Valencia
Avera Cancer Institute, Sioux Falls
USOR - Illinois Cancer Specialists - Niles, Niles
Winthrop P. Rockefeller Cancer Institute, Little Rock
Texas Oncology - Medical City Dallas, Dallas
USOR - Texas Oncology - Presbyterian Cancer Center Dallas, Dallas
USOR - Texas Oncology - Baylor Charles A. Sammons Cancer Center, Dallas
Texas Oncology Northeast Texas - Tyler, Tyler
University of Texas MD Anderson Cancer Center, Houston
USOR - Texas Oncology - San Antonio, San Antonio
Texas Oncology - Austin Midtown, Austin
Rocky Mountain Cancer Centers - Aurora, Aurora
University of Arizona Cancer Center, Tucson
Cancer Care Specialists - Nevada, Reno
Willamette Valley Cancer Institute and Research Center - Eugene, Eugene
USOR - Northwest Cancer Specialists, P.C. dba Compass Oncology - Vancouver Cancer Center, Vancouver
Kadlec Clinic - Hematology and Oncology, Richland
Hospital Español Auxilio Mutuo, San Juan
Hospital del Mar - Parc de Salut Mar, Barcelona
Institut Català d'Oncologia - Hospital Duran i Reynals (ICO L'Hospitalet), Barcelona
Lead Sponsor
ADC Therapeutics S.A.
INDUSTRY